A Retrospective Analysis of 450 TP53Mutations in a Real Life Cohort of CLL from the French Innovative Leukemia Organization (FILO) Group

MLA

Baran-Marszak, Fanny, et al. “A Retrospective Analysis of 450 TP53Mutations in a Real Life Cohort of CLL from the French Innovative Leukemia Organization (FILO) Group.” Blood, vol. 130, no. 1, Number 1 Supplement 1, Dec. 2017, p. 1722. EBSCOhost, https://doi.org/10.1182/blood.V130.Suppl_1.1722.1722.

APA

Baran-Marszak, F., Vidal, V., Hormi, M., Eclache, V., Veronese, L., Tournilhac, O., Davi, F., Nguyen-Khac, F., Leblond, V., Delabesse, E., Ysebaert, L., Bidet, A., Dilhuydy, M.-S., Poulain, S., Herbaux, C., Estienne, M.-H., Dartigeas, C., Pastoret, C., de Guibert, S., … Cymbalista, F. (2017). A Retrospective Analysis of 450 TP53Mutations in a Real Life Cohort of CLL from the French Innovative Leukemia Organization (FILO) Group. Blood, 130(1, Number 1 Supplement 1), 1722. https://doi.org/10.1182/blood.V130.Suppl_1.1722.1722

Chicago

Baran-Marszak, Fanny, Valerie Vidal, Myriam Hormi, Virginie Eclache, Lauren Veronese, Olivier Tournilhac, Frederic Davi, et al. 2017. “A Retrospective Analysis of 450 TP53Mutations in a Real Life Cohort of CLL from the French Innovative Leukemia Organization (FILO) Group.” Blood 130 (1, Number 1 Supplement 1): 1722. doi:10.1182/blood.V130.Suppl_1.1722.1722.